Antibody-mediated neutralization and binding-reversal studies on alpha-neurotoxins from Micrurus nigrocinctus nigrocinctus (coral snake) venom.

The research study explores the effect of antibodies in neutralizing and reversing the binding of alpha-neurotoxins, derived from the venom of Micrurus nigrocinctus nigrocinctus (coral snake), to the acetylcholine receptor (AchR). The study also emphasizes the therapeutic value of antivenom in treating envenomations even after neurological symptoms kickstart.

Methodology

• The researchers used a non-radioactive acetylcholine receptor (AchR) binding assay rooted in ELISA (Enzyme-Linked Immunosorbent Assay) to detect the alpha-neurotoxins in Micrurus nigrocinctus nigrocinctus venom.
• A hyperimmunization process was carried out on horses against the venom to produce vital antibodies.

Key Findings

• The research discovered that the sera from horses hyperimmunized against the venom comprises of antibodies that both inhibit the binding of alpha-neurotoxins to AchR and reverse the binding of toxins already complexed with the receptor.
• These findings underline the significant role of antivenom in treating M. n. nigrocinctus envenomations, especially after the start of neurological symptoms, differing from any presumptions that might assume antivenom to be ineffective after symptom onset.
• This efficacious impact of antivenom proceeds from its capacity to cross-react with several elapid alpha-neurotoxins and inhibit the binding of Bungarus multicinctus alpha-bungarotoxin and Naja naja oxiana neurotoxin II to AchR in vitro.

Identification of Toxins in Venom

• This cross-reactivity recommended the existence of both short-chain and long-chain alpha-neurotoxins in the venom of M. nigrocinctus.
• Moreover, in vivo neutralization experiments with M. nigrocinctus antivenom substantiated that the venom contains short-chain alpha-neurotoxin(s), which share common neutralizing epitope(s) with Naja naja oxiana neurotoxin II.

Implications

• The findings accentuate the need for comprehensive understanding of venom toxins to develop more efficient treatments against envenomations.
• The observations of how antibodies counteract these toxins open up possibilities for insights into the design and refinement of therapeutic strategies against various neurotoxic envenomations in the future.